Who Should Consider Tirzepatide or Phentermine
Severe gastrointestinal conditions: Those with delayed gastric emptying, gastroparesis, or chronic GI dysmotility may experience exacerbated symptoms due to the drugs action on gastric motility
,
Tirzepatide, by contrast, activates both GLP-1 and GIP receptorsa dual action that amplifies satiety, reduces appetite-driven behavior, and may increase the body's calorie-burning capacity
Newsome P, Francque S, Harrison S, Ratziu V, Van Gaal L, Calanna S, Hansen M, Linder M, Sanyal A
Patients at Risk of Cardiovascular Diseases Given its proven benefits in reducing cardiovascular events, semaglutide is an excellent option for individuals with type 2 diabetes who are at high risk of heart disease or stroke